文献速递脑血管病认知障碍与痴呆

尼莫地平在脑小血管病动物模型中保护血管与认知功能

Nimodipine Protects Vascular and Cognitive Function in an Animal Model of Cerebral Small Vessel Disease.
PubMed 文献 · Stroke · 2024-06-11

研究在自发性高血压卒中倾向大鼠中随机给予安慰剂(n=24)或尼莫地平(n=24)饮食,从3月龄至6月龄。尼莫地平组无卒中发生且生存率更高(P=0.0088),部分保留了神经血管耦合和神经代谢耦合,并改善了脑血管反应性和认知功能(P<0.001)。作者认为尼莫地平可能为脑小血管病的卒中和认知下降提供有效预防性治疗。

要点

  • 尼莫地平组无动物发生卒中,安慰剂组有6只因卒中提前终止,生存率更高(P=0.0088)。
  • 尼莫地平部分保留神经血管耦合和神经代谢耦合,反应更大(P<0.001)且更迅速(P<0.01)。
  • 尼莫地平组脑血管反应性更佳:小动脉扩张更大(P=0.015)、血流速度增加(P=0.001)。

核心结论

  • 慢性尼莫地平治疗在自发性高血压卒中倾向大鼠中预防卒中并保护血管和认知功能。
  • 作者认为尼莫地平可能为脑小血管病的卒中和认知下降提供有效预防性治疗。

研究设计与样本

  • 雄性自发性高血压卒中倾向大鼠在3至6月龄间随机接受安慰剂饮食(n=24)或尼莫地平饮食(n=24)。
  • 每日检查神经功能缺损,在3和6月龄评估神经血管和神经代谢耦合,6月龄评估脑血管反应性。
  • 6月龄时用新物体识别测试评估认知功能。

主要发现

  • 安慰剂组6只动物因卒中提前终止(包括1只因癫痫发作),尼莫地平组无动物发生卒中,生存率更高(P=0.0088)。
  • 尼莫地平组神经血管耦合和神经代谢耦合部分保留,表现为反应更大(P<0.001)、更迅速(P<0.01)及重复刺激后习惯化更少(P<0.01)。
  • 尼莫地平组脑血管反应性更佳,表现为小动脉扩张更大(P=0.015)和血流速度增加(P=0.001)。
  • 尼莫地平组血管和代谢功能的保护与更好的认知功能相关(P<0.001)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cerebral small vessel disease is a common cause of vascular cognitive impairment and dementia. There is an urgent need for preventative treatments for vascular cognitive impairment and dementia, and reducing vascular dysfunction may provide a therapeutic route. Here, we investigate whether the chronic administration of nimodipine, a central nervous system-selective dihydropyridine calcium channel blocking agent, protects vascular, metabolic, and cognitive function in an animal model of cerebral small vessel disease, the spontaneously hypertensive stroke-prone rat. METHODS: Male spontaneously hypertensive stroke-prone rats were randomly allocated to receive either a placebo (n=24) or nimodipine (n=24) diet between 3 and 6 months of age. Animals were examined daily for any neurological deficits, and vascular function was assessed in terms of neurovascular and neurometabolic coupling at 3 and 6 months of age, and cerebrovascular reactivity at 6 months of age. Cognitive function was evaluated using the novel object recognition test at 6 months of age. RESULTS: Six untreated control animals were terminated prematurely due to strokes, including one due to seizure, but no treated animals experienced strokes and so had a higher survival (P=0.0088). Vascular function was significantly impaired with disease progression, but nimodipine treatment partially preserved neurovascular coupling and neurometabolic coupling, indicated by larger (P<0.001) and more prompt responses (P<0.01), and less habituation upon repeated stimulation (P<0.01). Also, animals treated with nimodipine showed greater cerebrovascular reactivity, indicated by larger dilation of arterioles (P=0.015) and an increase in blood flow velocity (P=0.001). This protection of vascular and metabolic function achieved by nimodipine treatment was associated with better cognitive function (P<0.001) in the treated animals. CONCLUSIONS: Chronic treatment with nimodipine protects from strokes, and vascular and cognitive deficits in spontaneously hypertensive stroke-prone rat. Nimodipine may provide an effective preventive treatment for stroke and cognitive decline in cerebral small vessel disease.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Yang Z, Lange F, Xia Y, et al. Nimodipine Protects Vascular and Cognitive Function in an Animal Model of Cerebral Small Vessel Disease. Stroke. 2024. PMID: 38860370. doi:10.1161/STROKEAHA.124.047154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。